RetaNord sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use and have not been evaluated by the European Medicines Agency or any other regulatory authority.
Laboratories across the EU are studying GLP-1, GIP and glucagon receptor agonists and related compounds. RetaNord supplies research-grade material to that work — third-party HPLC-tested, 99%+ identity purity, with a lot-specific Certificate of Analysis in every box.
For laboratory and in-vitro research use only. Not for human or veterinary use, and not for use in diagnostic procedures. Not evaluated by the EMA, FDA or any regulatory authority.
In research, material is only as good as its documentation. Every RetaNord lot is independently analysed before it ships, and the lot number printed on the vial matches the CoA on file — so the compound on the bench can always be checked against the data. No documentation, no dispatch.
Every lot is tested through Veritalys, independent third-party peptide testing in the EU: HPLC for identity purity (99%+) and content, with identity confirmed against a reference standard, alongside pH, stability, sterility and endotoxin (LAL) checks. It is the same five-stage process applied to every product, described in plain terms so researchers know exactly what they are receiving.
RetaNord is deliberately narrow — documented material, not a long menu.
Triple-agonist research peptide (GLP-1 / GIP / glucagon). 99%+ HPLC. €89.95. Details →
Fifteen research peptides, supplied as sealed 10- or 30-vial kits. 99%+ HPLC. From €279. Details →
0.9% benzyl alcohol — the diluent for reconstituting lyophilised peptides. €5.00. Details →
Every order ships within 24–48 hours with full analytical documentation in the box. For laboratory research use only.
Browse the catalogA person answers every message — the same day, seven days a week.